Cincinnati Children's Hospital Medical Center

Essais liés26clinical trials

VilleCincinnatilocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05691478

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Mycophenolate Mofetil	Lupus	Phase 2	NCT05538208	The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study	RECRUITING
Biopsy Procedure	Cancer	Phase 1/2	NCT05099003	A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)	RECRUITING
Biopsy Procedure	Cancer	Phase 2	NCT06064097	A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)	RECRUITING
Lasmiditan	Migraine	Phase 3	NCT04396236	PIONEER-PEDS1 — A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine	TERMINATED
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy	Myopathies	À vérifier	NCT06503367	Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy	RECRUITING
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy	Myopathies	À vérifier	NCT07092540	The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy	RECRUITING
Emapalumab	Lupus	Phase 3	NCT05001737	EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE	COMPLETED
Deramiocel (CAP-1002)	Myopathies	Phase 3	NCT05126758	HOPE-3 — A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	ACTIVE_NOT_RECRUITING
Galcanezumab	Migraine	Phase 3	NCT04616326	REBUILD-2 — A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine	ACTIVE_NOT_RECRUITING
Lasmiditan	Migraine	Phase 3	NCT04396574	PIONEER-PEDS2 — A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine	TERMINATED
Biospecimen Collection	Cancer	Phase 3	NCT05675410	A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab	RECRUITING
Bone Scan	Cancer	Phase 2/3	NCT05691478	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	SUSPENDED
Descartes-08	Lupus	Phase 1/2	NCT07089121	Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders	RECRUITING
Vamorolone	Myopathies	À vérifier	NCT06564974	DMD-001 SUMMIT — Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT	RECRUITING
EXCEL — A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition	Myopathies	À vérifier	NCT06581146	EXCEL — A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition	RECRUITING
CC-97540	Lupus	Phase 2	NCT07015983	A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)	ACTIVE_NOT_RECRUITING
Galcanezumab	Migraine	Phase 3	NCT03432286	REBUILD-1 — A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine	ACTIVE_NOT_RECRUITING
Mind Body Balance for Pediatric Migraine	Migraine	Non applicable	NCT04715685	Mind Body Balance for Pediatric Migraine	RECRUITING
Rimegepant	Migraine	Phase 3	NCT05156398	Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	RECRUITING
Rimegepant	Migraine	Phase 3	NCT06616194	A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine	ACTIVE_NOT_RECRUITING
Amitriptyline	Migraine	Non applicable	NCT05889624	Responding With Evidence and Access for Childhood Headaches	RECRUITING
Clemizole HCl	Épilepsie	Phase 3	NCT04462770	ARGUS — A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	RECRUITING
BE WELL With Migraine: Brain Education and WELLness With Migraine	Migraine	Non applicable	NCT05987592	BE WELL With Migraine: Brain Education and WELLness With Migraine	RECRUITING
Rimegepant/BHV3000	Migraine	Phase 3	NCT04649242	Randomized Study in Children and Adolescents With Migraine: Acute Treatment	RECRUITING
Casimersen	Myopathies	Phase 3	NCT03532542	An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy	TERMINATED
baclofen	Myopathies	Phase 1	NCT00607542	Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity	COMPLETED